Sort
82,697 grants matching “vaccine development”
Implementing Community-based Approaches to Increase SARS-CoV-2 Testing among an Underserved and Vulnerable Hispanic Population
$690,902Robert Kirken · University Of Texas El Paso · U54 · FY2021 · MD
Development and Testing of New Tuberculosis Vaccines
$690,878Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2008 · AI
Tuberculosis and T cell Recognition
$690,876Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI
Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms
$690,821Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · MH
Effect of host immunity stimulated by viral IL-10-deleted RhCMV vaccines on SIV rebound
$690,805Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2020 · AI
Proteogenomics of dysregulated protein interaction networks in MTB infection
$690,731W. Henry Henry Boom · Case Western Reserve University · R01 · FY2012 · HL
Evolutionary genetics of tsetse and its symbionts
$690,730Serap Aksoy · Yale University · R01 · FY2011 · AI
Task A71: Evaluation of Therapeutics and Vaccines in Mouse Models of Dengue Virus
$690,722Alan D.t. Barrett · University Of Texas Med Br Galveston · N01 · FY2016 · AI
Murine Memory B cell Development and Function
$690,672Mark J Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
NKT cells as modulators of AIDS vaccine efficacy
$690,636Amitinder Kaur · Tulane University Of Louisiana · R01 · FY2014 · AI
Vaccine Development for Burkholderia amllei and B. pseudomallei
$690,511Alfredo G Torres · University Of Texas Med Br Galveston · U54 · FY2013 · AI
Pathogen recognition and induction of innate immunity and inflammation against
$690,457Michael J Gale · University Of Washington · U19 · FY2016 · AI
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$690,447Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Pathogenesis Studies Of Simian Immunodeficiency Virus Infection Of Monkeys
$690,447Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
New Approaches To Passive Immunoprophylaxis
$690,432Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
MACAQUE MODEL OF THERAPEUTIC IMMUNIZATION AGAINST HIV
$690,390University Of Kansas Medical Center · R01 · FY2003 · RR
Prime shock and kill for HIV erradication
$690,241Andrew D Badley · Mayo Clinic Rochester · R01 · FY2017 · AI
Prime shock and kill for HIV erradication
$690,241Andrew D Badley · Mayo Clinic Rochester · R01 · FY2016 · AI
New Strategy to Improve Gastrointestinal Health in SIV/HIV
$690,235Cristian Apetrei · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Developing Immunotherapeutics for Methamphetamine Abuse
$690,027Frank M Orson · Baylor College Of Medicine · U01 · FY2010 · DA
An immunodominance-based Pan-Pneumovirus vaccine for protection against RSV and hMPV
$690,023Jarrod Mousa · Florida State University · R01 · FY2024 · AI
Robust, defined, animal-free cell culture medium for the production of vaccines
$689,933Steve Clyde Pettit · Ventria Bioscience · R44 · FY2012 · AI
Replication of influenza virus
$689,912Robert M Krug · University Of Texas At Austin · R01 · FY2012 · AI
Diversity of TFH cells and DSA generation after kidney transplantation
$689,885Diana M Metes · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
Nab evolution in humans and RMs
$689,879Garnett H Kelsoe · University Of Pennsylvania · P01 · FY2020 · AI